Status:
UNKNOWN
A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue
Lead Sponsor:
Namida Lab
Conditions:
Breast Cancer Screening
Eligibility:
FEMALE
18-100 years
Brief Summary
Investigation of a tear-based, lab-developed biological test for breast cancer, as a supplemental tool to current screening recommendations for women with dense breast tissue will explore if a tear-ba...
Eligibility Criteria
Inclusion
- Categorized as having heterogeneously dense or extremely dense tissue 18 years of age or older Able to understand the informed consent process Willing to comply with all study procedures
Exclusion
- Have an active eye infection Categorized as having fibro glandular densities or fatty breast tissue Currently diagnosed or are receiving treatment for breast cancer Under 18 years of age
Key Trial Info
Start Date :
October 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT05268224
Start Date
October 1 2021
End Date
October 1 2024
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Namida Lab
Fayetteville, Arkansas, United States, 72703